It has the highest number of patients with thalassemia major in the world. India has around 50 million (5 crore) carriers of the ß (beta) thalassemia trait. Over 10,000-15000 new cases of ...

Editas Medicine struggles with underwhelming data and lacks major partnerships. Find out why EDIT stock faces significant ...

Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, today announced the appointment of Joseph Bolen, Ph.D., as Chief ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle ... Edge gives you instant access to all major analyst upgrades, downgrades, and ...

We recently published a list of 12 Incredibly Cheap Dividend Stocks to Buy Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other ...

and transfusion-dependent beta-thalassemia (TDT) — in the United States and Europe. VRTX leads the global development and commercialization of Casgevy under the terms of the 2021 agreement ...

However, there are still several questions surrounding the performance of obesity drugs, as major players in the ... and transfusion-dependent beta-thalassemia (TDT). The company’s product ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Michelle Harlan, who has sickle beta thalassemia, wants to help others by getting a doctoral degree in clinical psychology.